Molecular Mechanisms of Blood-Brain Barrier Function and Dysfunction in Alzheimer's disease and Alzheimer's related dementias (AD/ADRD) (R01 Clinical Trial Not Allowed)

Funding Agency:
National Institutes of Health

The goal of this initiative is to elucidate the mechanistic links between blood brain barrier (BBB) dysfunction, Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD), and how related comorbidities impact the basic molecular mechanisms of BBB health and function.


  • Letter of Intent Due Date(s): September 9, 2019
  • Application Due Date(s): October 9, 2019

RFA-NS-20-004 Expiration Date October 10, 2019

Agency Website

Amount Description

Application budgets are limited to $499,000 direct costs/year and need to reflect the actual needs of the proposed project.

The maximum project period is 5 years.

Funding Type





Medical - Basic Science

External Deadline

October 9, 2019